Last Close
May 15  •  04:00PM ET
6.27
Dollar change
-0.16
Percentage change
-2.49
%
Index
-
P/E
-
EPS (ttm)
-1.81
Insider Own
38.23%
Shs Outstand
8.13M
Perf Week
-2.18%
Market Cap
52.01M
Forward P/E
-
EPS next Y
-0.41
Insider Trans
-0.55%
Shs Float
5.12M
Perf Month
-6.14%
Enterprise Value
52.66M
PEG
-
EPS next Q
-0.38
Inst Own
10.54%
Perf Quarter
15.47%
Income
-15.38M
P/S
1.49
EPS this Y
8.18%
Inst Trans
6.31%
Perf Half Y
3.47%
Sales
34.90M
P/B
-
EPS next Y
72.94%
ROA
-97.59%
Perf YTD
39.80%
Book/sh
-0.70
P/C
5.89
EPS next 5Y
-
ROE
-478.70%
52W High
8.64 -27.43%
Perf Year
26.67%
Cash/sh
1.06
P/FCF
-
EPS past 3/5Y
29.44% 28.87%
ROIC
-485.39%
52W Low
4.16 50.72%
Perf 3Y
-6.28%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
55.06% 55.74%
Gross Margin
85.57%
Volatility
8.92% 8.13%
Perf 5Y
-73.71%
Dividend TTM
-
EV/Sales
1.51
EPS Y/Y TTM
-10.81%
Oper. Margin
-41.97%
ATR (14)
0.56
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.86
Sales Y/Y TTM
31.90%
Profit Margin
-44.08%
RSI (14)
46.76
Dividend Gr. 3/5Y
- -
Current Ratio
1.02
EPS Q/Q
-26.57%
SMA20
-1.91%
Beta
0.67
Payout
-
Debt/Eq
-
Sales Q/Q
42.64%
SMA50
-2.32%
Rel Volume
2.88
Prev Close
6.43
Employees
83
LT Debt/Eq
-
SMA200
9.54%
Avg Volume
63.35K
Price
6.27
IPO
Jun 22, 2018
Option/Short
No / Yes
Trades
Volume
182,474
Change
-2.49%
Date Action Analyst Rating Change Price Target Change
Aug-14-20Upgrade BTIG Research Neutral → Buy $3.50
Nov-14-19Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-26-19Resumed Cantor Fitzgerald Neutral $9
May-30-19Downgrade Cantor Fitzgerald Overweight → Neutral
May-15-19Downgrade BTIG Research Buy → Neutral
May-09-19Initiated Noble Capital Markets Outperform
Sep-21-18Initiated Cantor Fitzgerald Overweight
May-13-26 08:00AM
May-08-26 08:00PM
May-07-26 08:30AM
May-06-26 04:05PM
Apr-30-26 08:00AM
08:00AM Loading…
Apr-29-26 08:00AM
Apr-28-26 08:00AM
Apr-23-26 08:00AM
Apr-08-26 08:00AM
Apr-07-26 08:00AM
Apr-01-26 08:00AM
Mar-31-26 08:00AM
Mar-30-26 08:00AM
Mar-26-26 03:11AM
Mar-23-26 09:01PM
08:12PM Loading…
Mar-19-26 08:12PM
04:05PM
Mar-18-26 12:15PM
Mar-10-26 08:00AM
Mar-09-26 08:00AM
Mar-05-26 10:00AM
Mar-04-26 05:55PM
10:00AM
Feb-27-26 07:15AM
Jan-21-26 08:00AM
Jan-20-26 08:00AM
Dec-02-25 08:00AM
Nov-10-25 04:05PM
Nov-05-25 06:35PM
04:05PM
08:50AM Loading…
Nov-04-25 08:50AM
Oct-29-25 10:00AM
Oct-23-25 08:11AM
Oct-03-25 04:05PM
Sep-30-25 08:00AM
Sep-29-25 08:00AM
Sep-22-25 08:00AM
Sep-10-25 04:05PM
Sep-05-25 08:00AM
Sep-04-25 08:00AM
Sep-03-25 08:00AM
Sep-02-25 08:00AM
Aug-12-25 08:00AM
Aug-06-25 05:35PM
04:05PM
Aug-05-25 05:55PM
10:35AM
08:00AM
Jul-23-25 08:00AM
Jul-22-25 04:05PM
Jul-14-25 10:01AM
May-09-25 11:00AM
May-07-25 11:18PM
11:16PM
06:15PM
04:05PM
01:36PM
May-05-25 04:48AM
May-02-25 08:00AM
May-01-25 08:00AM
Apr-30-25 08:00AM
Apr-17-25 08:00AM
Apr-16-25 08:00AM
Apr-03-25 08:00AM
Apr-01-25 08:00AM
Mar-31-25 08:00AM
Mar-13-25 03:11AM
Mar-12-25 05:15PM
04:05PM
Mar-06-25 08:00AM
Mar-05-25 08:00AM
Feb-27-25 08:00AM
Feb-19-25 08:00AM
Feb-18-25 07:59AM
Feb-06-25 08:00AM
Feb-04-25 08:00AM
Jan-07-25 08:00AM
Jan-02-25 11:09AM
Dec-17-24 04:05PM
04:05PM
Nov-20-24 08:00AM
Nov-19-24 08:00AM
Nov-14-24 08:00AM
02:16AM
Nov-13-24 05:15PM
04:01PM
Nov-12-24 04:01PM
Nov-11-24 04:13AM
Nov-08-24 04:01PM
Oct-23-24 08:00AM
Oct-22-24 05:51PM
10:20AM
Oct-14-24 08:00AM
Oct-09-24 05:19PM
Sep-26-24 08:00AM
Sep-24-24 08:00AM
Sep-10-24 08:00AM
Sep-04-24 08:00AM
02:00AM
Aug-08-24 08:00AM
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
Founder & Independent ChairmanDr. Thomas J. Errico M.D.
CFO & Interim PresidentMr. Joshua S. Lev
Chief Operating OfficerMr. Michael Fox
Senior Vice President of EngineeringMr. Donald Melnikoff
Vice President of Global Sales & Business DevelopmentMr. Mitch Deshon
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldberger Daniel SFormer AffiliateMay 14 '26Proposed Sale6.4845,000291,600May 14 03:48 PM
Goldberger Daniel SFormer Affiliate May 05 '26Proposed Sale6.7225,000168,000May 05 10:37 AM
Goldberger Daniel SFormer CEOApr 23 '26Proposed Sale6.1310,00061,300Apr 23 12:43 PM
Goldberger Daniel SFormer Officer and DirectorApr 10 '26Sale6.0216,07296,753291,471Apr 14 04:05 PM
Lev Joshua S.Chief Financial OfficerDec 04 '25Sale5.052,50012,62521,667Dec 05 04:15 PM
Goldberger Daniel SChief Executive OfficerDec 02 '25Buy4.841,0004,840292,565Dec 03 07:00 AM
Lev Joshua S.Chief Financial OfficerNov 12 '25Sale6.182,16613,38623,667Nov 14 04:33 PM
Errico Thomas J.DirectorAug 11 '25Buy4.4715,00067,050281,401Aug 13 06:05 AM
Goldberger Daniel SChief Executive OfficerAug 11 '25Buy4.231,0004,230291,565Aug 12 06:05 AM
GANDOLFO JOHN PDirectorMay 23 '25Buy5.011,8009,01869,087May 27 09:27 AM